Single-Use Bioprocessing Market to Hit USD 34.9 Billion by 2029, Surging at 14.5% CAGR | MarketsandMarkets™ [Yahoo! Finance]
Danaher Corporation (DHR)
Last danaher corporation earnings: 1/30 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.danaher.com
Company Research
Source: Yahoo! Finance
17.7 billion in 2024, with a CAGR of 14.5%. Key players such as Sartorius AG, Danaher Corporation, Thermo Fisher Scientific, Inc., and Merck KGaA dominate 44-48% of the market share globally. Factors driving market growth include increased adoption among CDMOs & CMOs, enhanced productivity, reduced risk of contamination, lower capital investment, and improved environmental sustainability. However, challenges like leachables & extractables, regulatory compliance issues, and PFAS restrictions may hinder growth. Merck KGaA, with its broad product portfolio and global presence, is positioned for significant growth. Danaher Corporation, especially after acquiring Pall Corporation, and Sartorius AG, with their strategic expansions and innovative product offerings, also hold prominent positions in the market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231651297 Browse in-depth TOC on " Single-Use Bioprocessing Market 739 - Tables 61 - Figures 595 - P
Show less
Read more
Impact Snapshot
Event Time:
DHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DHR alerts
High impacting Danaher Corporation news events
Weekly update
A roundup of the hottest topics
DHR
News
- Danaher Co. (NYSE: DHR) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Danaher Schedules Second Quarter 2024 Earnings Conference CallPR Newswire
- Global Rubella Diagnostic Testing Market Size To Worth USD 2.23 Billion By 2033 | CAGR Of 5.15% [Yahoo! Finance]Yahoo! Finance
- Did Danaher Corporation (DHR) Get a Good Analyst Rating for Its Q1 Performance? [Yahoo! Finance]Yahoo! Finance
- Integrated DNA Technologies Introduces New HIV Panel to Advance Virology Research [Yahoo! Finance]Yahoo! Finance
DHR
Earnings
- 4/23/24 - Beat
DHR
Sec Filings
- 6/20/24 - Form 8-K
- 6/7/24 - Form 11-K
- 5/17/24 - Form 4
- DHR's page on the SEC website